News and Analysis
Innovation, Technology, and IP News
FDA Releases Draft Guidances on 510(k) Submissions
Written by: Paige L. Cappelli On September 6, 2023, the U.S. Food & Drug Administration (FDA) released three draft guidance documents to provide updated...
IPR Decision Based on a Barely Mentioned Typo Violated the APA Notice Requirement
Written by:Brianne M. Kingery & Daniel Kiang APPLE INC. v. COREPHOTONICS, LTD. Before Stoll, Linn, and Stark. Appeal from the Patent Trial and Appeal Board. Summary: An IPR...
“Magic Words” Unnecessary in Identifying Field of Endeavor for Analogous Art
Written by: Raymond S. Lu & Daniel Kiang NETFLIX, INC. v. DivX, LLC Before Hughes, Stoll, and Stark. Appeal from the Patent Trial and Appeal Board. Summary...
CASE OF THE WEEK
Baxalta Inc. v. Genentech, Inc., Appeal No. 22-1461 (Fed. Cir. Sept. 20, 2023)
Our Case of the Week focuses... Read More »
Written by: Ashley C. Morales & Joseph Mallon, Ph.D.
In Baxalta Incorporated v. Genentech, Inc., 2022-1461, the Federal Circuit... Read More »
CASE OF THE WEEK
Columbia Sportswear North America, Inc. v. Seirus Innovative Accessories, Inc., Appeal Nos. 2021-2299, -2338 (Fed. Cir... Read More »
Written by: Rhett D. Ramsey & Jacob R. Rosenbaum
Elekta Limited v. Zap Surgical Systems, Inc.
Before: Reyna, Stoll, and... Read More »
In the ever-evolving landscape of patent law, the Court of Appeals for the Federal Circuit (CAFC) has played a pivotal role in shaping the ... Read More »
Written by: Paige L. Cappelli
On September 6, 2023, the U.S. Food & Drug Administration (FDA) released three draft... Read More »
Written by:Brianne M. Kingery & Daniel Kiang
APPLE INC. v. COREPHOTONICS, LTD.
Before Stoll, Linn, and Stark. Appeal from the... Read More »
Written by: Raymond S. Lu & Daniel Kiang
NETFLIX, INC. v. DivX, LLC
Before Hughes, Stoll, and Stark. Appeal from the ... Read More »
In the dynamic realm of intellectual property, remaining at the forefront is absolutely essential. Tomorrow marks the release of a pivotal... Read More »
Written by: Ari Feinstein & Jane Dai, Ph.D.
On June 2, 2023, drug manufacturer Shire US Inc. and related entity Shire LLC... Read More »
In the world of patent law, Post-Grant Review (PGR) and Inter Partes Review (IPR) are crucial mechanisms for challenging... Read More »
Written by: Eric Wittgrove
Medtronic Minimed, Inc. and Minimed Distribution Corp. (“Medtronic”) were sued in a class... Read More »
Written by: Nima Zargari, Ph.D.
On August 15, 2023, the Food and Drug Administration (FDA) issued its updated guidance on... Read More »
In a significant turn of events, Google has secured a major legal victory as a Delaware federal judge has ruled to nullify... Read More »
CASE OF THE WEEK
In re Cellect, LLC, Appeal Nos. 2022-1293, -1294, -1295, -1296 (Fed. Cir. Aug. 28, 2023)
In a significant... Read More »
Written by: Christopher L. Lewis
Recent reports, including one by PitchBook, indicate that both venture capitalist funding for... Read More »
CASE OF THE WEEK
Volvo Penta of the Americas, LLC v. Brunswick Corp., Appeal No. 2022-1765 (Fed. Cir. Aug. 24, 2023)
In its... Read More »
Written by: Nefi R. Oliva & Nathan D. Reeves
IN RE CELLECT, LLC
Before Lourie, Dyk, and Reyna. Appeal from the... Read More »
We are proud to announce that tomorrow marks the release of the fourth edition of our ANDA Litigation Intelligence Report. This year's report... Read More »
Written by: Alistair J. McIntyre & Brandon G. Smith
Volvo Penta of the Americas, LLC, v. Brunswick Corp.
Before Moore... Read More »
